Funds and ETFs Abbott Laboratories

Equities

ABT

US0028241000

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 04:00:02 2024-04-26 pm EDT 5-day change 1st Jan Change
107.5 USD +0.63% Intraday chart for Abbott Laboratories +0.23% -2.31%

ETFs positioned on Abbott Laboratories

Name Weight AuM 1st Jan change Investor Rating
7.18% 18 M€ +3.79% -
5.19% 2 M€ -.--%
3.00% 2 M€ -.--% -
2.34% 9 M€ -.--% -
2.02% 1 M€ +16.32%
1.88% 2 M€ +21.73% -
1.80% 5 M€ -72.95% -
1.76% 1 M€ +2.21% -
1.30% 40 M€ -.--%
1.20% 2 M€ +6.77%
1.12% 8 M€ +2.44%
1.00% 204 M€ +10.54%
0.94% 330 M€ -.--% -
0.77% 282 M€ +3.59% -
0.76% 1,174 M€ +23.54%
0.76% 655 M€ -.--% -
0.76% 273 M€ -.--%
0.76% 105 M€ +6.17%
0.69% 27 M€ +17.28% -
0.67% 8 M€ +5.48% -
0.66% 559 M€ +14.30% -
0.66% 1,848 M€ +18.39% -
0.65% 1 M€ +0.04%
0.60% 9 M€ +2.75% -
0.60% 736 M€ +6.09%
0.60% 6 M€ +17.98% -
0.60% 125 M€ +4.43% -
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
107.5 USD
Average target price
126.3 USD
Spread / Average Target
+17.49%
Consensus
  1. Stock Market
  2. Equities
  3. ABT Stock
  4. Funds and ETFs Abbott Laboratories